Biliary Stents Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Japan, India, China, Australia, Brazil, Mexico, Argentina, Saudi Arabia, South Africa, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025
Report ID: GMI4034
Biliary Stents Market size is projected to experience significant growth from 2019 to 2025.
Increasing prevalence of biliary diseases will drive the biliary stents market growth. Biliary tract disease is considered as one of the most common cause for biliary obstruction. According to the British Society of Gastroenterology, more than 15,000 individuals in the UK live with consequences of chronic biliary inflammation. Thus, rising number of biliary diseases will impel the biliary stents market growth in the coming years.
Technological advancements in biliary stents will provide new ways to revolutionize the treatment of biliary disorders. Plastic stents were introduced for the ease of placement of stents in the system. Thus, developments in biliary stenting procedures will further increase the efficiency of stent placement. Such novel approaches in the treatment of biliary diseases will offer lucrative opportunities to global biliary stents industry growth in the forthcoming years.
However, stringent government regulations related to biliary stents might restrain biliary stents market growth in coming years.
Metal biliary stents market will foresee significant growth over coming period due to increasing use of metal stents for the treatment of biliary tract diseases. Metal stent provides longer stent patency as compared to plastic stents. Metal stents are available depending on its expansion capacity, that should further lead to greater customer adoption due to better benefits. Enhanced patency coupled with increasing innovations in metal biliary stents will drive the metal biliary stents market growth in the upcoming years.
Gallstones application segment of the biliary stents market will witness rapid progress at significant CAGR. Among all biliary diseases, gallstones is most common condition. Biliary stents are used to remove bile duct blockages. As per the World Gastroenterology Organization, around 20 million Americans suffer from gallstones. Thus, growing incidence of gallstone diseases among the population will boost the segmental growth.
Demand for biliary stents in hospitals will escalate at momentous pace in upcoming years. Growing adoption and preference for minimally invasive procedures will lead to high demand for the biliary stents. Presence of multiple specialties, sophisticated infrastructure and skilled professionals for doing advanced procedures will escalate the segmental growth. Furthermore, growing disease prevalence along with reimbursement policies for biliary stenting will boost the biliary stents market growth in the foreseeable future.
U.S. biliary stents market will hold significant market share during projected timeframe. According to the World Gastroenterology Organization, about 15% of the U.S. population suffer from gallstones. The National Health and Nutrition Examination Survey indicated higher prevalence of gallstones in Mexicans and Americans. Thus, high incidence of gallstones will provide robust demand potential for the biliary stents in the country. In addition, growing elderly population that possess greater susceptibility for biliary disorders will spur the U.S. biliary stents industry growth.
China biliary stents market will grow at considerable rate over the estimation period. Expanding geriatric population will be a significant factor in boosting the market size. Changing lifestyle and food habits among the Chinese population is leading to greater risk of developing biliary diseases including biliary tract cancer. Aforementioned factors coupled with rising adoption of innovative technologies will stimulate the China biliary stents market growth.
Some of the players operating in the global biliary stents market are GE healthcare, Brainlab, Boston Scientific Corporation, Stryker and Medtronic among few other players. Developments in biliary stents will provide lucrative opportunities to the firms for market expansion and to strengthen their position in the biliary stents industry. For instance, in March 2019, BrightWater Medical Inc. received the U.S. FDA approval for ConvertX Biliary stents for treatment of bile duct obstructions, leading to business expansion.
Biliary Stents Market, by Type, 2014-2025 (USD Million)
- Metal Stents
- Plastic Stents
Biliary Stents Market, by Application, 2014-2025 (USD Million)
- Biliary leaks
Biliary Stents Market, by End-use, 2014-2025 (USD Million)
- Ambulatory Surgical Centers
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- Blue Belt Technologies
- Boston Scientific Corporation
- Claron Technology
- GE Healthcare
- Karl Storz
- Medacta International
- Medtronic plc
- Stryker Corporation
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability